Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Calyxt, Inc. stock logo
CLXT
Calyxt
$6.30
$13.58
$1.25
$7.77
$31.31M1.98139,308 shs254,056 shs
Evogene Ltd. stock logo
EVGN
Evogene
$1.17
-0.9%
$1.26
$0.95
$3.32
$6.29M1.16778,796 shs85,194 shs
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
$0.80
$0.80
$0.55
$1.55
$145.56M0.36919,497 shs38 shs
CVR Partners, LP stock logo
UAN
CVR Partners
$90.44
-0.6%
$90.30
$62.94
$98.99
$1.55B1.1627,107 shs25,461 shs
(WYN) stock logo
WYN
(WYN)
$108.44
$108.44
$95.30
$127.96
N/AN/A2.44 million shs2.77 million shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Calyxt, Inc. stock logo
CLXT
Calyxt
0.00%0.00%0.00%0.00%0.00%
Evogene Ltd. stock logo
EVGN
Evogene
0.00%-6.85%-9.35%-14.28%-56.19%
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
0.00%0.00%0.00%0.00%0.00%
CVR Partners, LP stock logo
UAN
CVR Partners
0.00%+3.39%+1.03%+0.09%+30.09%
(WYN) stock logo
WYN
(WYN)
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Calyxt, Inc. stock logo
CLXT
Calyxt
$6.30
$13.58
$1.25
$7.77
$31.31M1.98139,308 shs254,056 shs
Evogene Ltd. stock logo
EVGN
Evogene
$1.17
-0.9%
$1.26
$0.95
$3.32
$6.29M1.16778,796 shs85,194 shs
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
$0.80
$0.80
$0.55
$1.55
$145.56M0.36919,497 shs38 shs
CVR Partners, LP stock logo
UAN
CVR Partners
$90.44
-0.6%
$90.30
$62.94
$98.99
$1.55B1.1627,107 shs25,461 shs
(WYN) stock logo
WYN
(WYN)
$108.44
$108.44
$95.30
$127.96
N/AN/A2.44 million shs2.77 million shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Calyxt, Inc. stock logo
CLXT
Calyxt
0.00%0.00%0.00%0.00%0.00%
Evogene Ltd. stock logo
EVGN
Evogene
0.00%-6.85%-9.35%-14.28%-56.19%
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
0.00%0.00%0.00%0.00%0.00%
CVR Partners, LP stock logo
UAN
CVR Partners
0.00%+3.39%+1.03%+0.09%+30.09%
(WYN) stock logo
WYN
(WYN)
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Calyxt, Inc. stock logo
CLXT
Calyxt
0.00
N/AN/AN/A
Evogene Ltd. stock logo
EVGN
Evogene
3.50
Strong Buy$3.50198.63% Upside
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
0.00
N/AN/AN/A
CVR Partners, LP stock logo
UAN
CVR Partners
0.00
N/AN/AN/A
(WYN) stock logo
WYN
(WYN)
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest UAN, EVGN, MBII, WYN, and CLXT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/11/2025
Evogene Ltd. stock logo
EVGN
Evogene
Alliance Global Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
(Data available from 9/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Calyxt, Inc. stock logo
CLXT
Calyxt
$160K195.69N/AN/A$0.54 per share11.67
Evogene Ltd. stock logo
EVGN
Evogene
$8.51M0.74N/AN/A$2.77 per share0.42
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
$44.31M3.28N/AN/A$0.17 per share4.69
CVR Partners, LP stock logo
UAN
CVR Partners
$525.32M2.95$8.69 per share10.41$17.12 per share5.28
(WYN) stock logo
WYN
(WYN)
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Calyxt, Inc. stock logo
CLXT
Calyxt
-$16.89M-$3.49N/AN/AN/A-9,979.64%-259.69%-83.22%N/A
Evogene Ltd. stock logo
EVGN
Evogene
-$16.49M-$2.25N/AN/A-211.61%-109.96%-38.47%11/20/2025 (Estimated)
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
-$16.55M-$0.12N/AN/AN/A-47.07%-70.87%-25.23%N/A
CVR Partners, LP stock logo
UAN
CVR Partners
$60.90M$8.3210.87N/A15.27%29.35%8.76%10/27/2025 (Estimated)
(WYN) stock logo
WYN
(WYN)
N/A$6.0417.95N/AN/AN/AN/AN/A

Latest UAN, EVGN, MBII, WYN, and CLXT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
CVR Partners, LP stock logo
UAN
CVR Partners
N/A$3.67N/A$3.67N/A$168.56 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Calyxt, Inc. stock logo
CLXT
Calyxt
N/AN/AN/AN/AN/A
Evogene Ltd. stock logo
EVGN
Evogene
N/AN/AN/AN/AN/A
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
N/AN/AN/AN/AN/A
CVR Partners, LP stock logo
UAN
CVR Partners
$15.5617.21%N/A187.02%1 Years
(WYN) stock logo
WYN
(WYN)
$2.642.43%N/A43.71%N/A

Latest UAN, EVGN, MBII, WYN, and CLXT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/30/2025
CVR Partners, LP stock logo
UAN
CVR Partners
quarterly$3.8916.01%8/11/20258/11/20258/18/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Calyxt, Inc. stock logo
CLXT
Calyxt
N/A
0.61
0.61
Evogene Ltd. stock logo
EVGN
Evogene
N/A
1.89
1.76
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
0.33
0.79
0.55
CVR Partners, LP stock logo
UAN
CVR Partners
1.80
3.45
2.40
(WYN) stock logo
WYN
(WYN)
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Calyxt, Inc. stock logo
CLXT
Calyxt
6.77%
Evogene Ltd. stock logo
EVGN
Evogene
10.40%
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
68.42%
CVR Partners, LP stock logo
UAN
CVR Partners
43.83%
(WYN) stock logo
WYN
(WYN)
90.14%

Insider Ownership

CompanyInsider Ownership
Calyxt, Inc. stock logo
CLXT
Calyxt
2.20%
Evogene Ltd. stock logo
EVGN
Evogene
7.40%
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
5.00%
CVR Partners, LP stock logo
UAN
CVR Partners
0.36%
(WYN) stock logo
WYN
(WYN)
2.18%
CompanyEmployeesShares OutstandingFree FloatOptionable
Calyxt, Inc. stock logo
CLXT
Calyxt
484.97 million4.87 millionNot Optionable
Evogene Ltd. stock logo
EVGN
Evogene
1405.37 million4.97 millionOptionable
Marrone Bio Innovations, Inc. stock logo
MBII
Marrone Bio Innovations
153182.38 million173.26 millionNot Optionable
CVR Partners, LP stock logo
UAN
CVR Partners
30017.12 million17.06 millionOptionable
(WYN) stock logo
WYN
(WYN)
N/AN/AN/AOptionable

Recent News About These Companies

West Wales farmer improves manure consistency with spreader
Watermelons grown from seed? ‘Worth every cent’: Wyn Drabble
Tourist costs at hot spots could cost us - Wyn Drabble

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Calyxt stock logo

Calyxt NASDAQ:CLXT

Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company to enhance the quality of alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota.

Evogene stock logo

Evogene NASDAQ:EVGN

$1.17 -0.01 (-0.93%)
Closing price 03:59 PM Eastern
Extended Trading
$1.17 0.00 (-0.17%)
As of 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

Marrone Bio Innovations stock logo

Marrone Bio Innovations NASDAQ:MBII

Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.

CVR Partners stock logo

CVR Partners NYSE:UAN

$90.44 -0.59 (-0.64%)
Closing price 03:58 PM Eastern
Extended Trading
$90.36 -0.07 (-0.08%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CVR Partners, LP, together with its subsidiaries, engages in the production and sale of nitrogen fertilizer products in the United States. The company offers ammonia products for agricultural and industrial customers; and urea ammonium nitrate products to agricultural customers, as well as retailers and distributors. CVR GP, LLC serves as the general partner of the company. CVR Partners, LP was incorporated in 2007 and is based in Sugar Land, Texas. CVR Partners, LP is a subsidiary of CVR Energy, Inc.

(WYN) stock logo

(WYN) NYSE:WYN

Travel + Leisure Co. is a membership and leisure travel company, with a portfolio of nearly 20 resort, travel club, and lifestyle travel brands. The company provides outstanding vacation experiences and travel inspiration to millions of owners, members, and subscribers every year through its products and services: Wyndham Destinations, the vacation ownership company with 230 vacation club resort locations across the globe; Panorama, the membership travel business that includes the vacation exchange company, industry travel technology, and subscription travel brands; and Travel + Leisure Group, featuring online and print travel content, online booking platforms and travel clubs, and branded consumer products. Travel + Leisure Co. is a membership and leisure travel company, with a portfolio of nearly 20 resort, travel club, and lifestyle travel brands. Travel + Leisure was founded on July 31, 2006 and is headquartered in Orlando, FL.